[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:stargardt-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":114,"states":119},"Stargardt Disease",17,15,[8,16,22,28,34,41,48,54,60,66,72,77,83,89,95,101,108],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06942572","A Phase 1\u002F2, First-in-Human Dose Escalation\u002FExpansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:19.975067Z","2026-05-05T02:43:29.391410Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06467344","Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)",[12],"2026-08-26T02:15:22.311223Z","2026-05-05T02:43:28.311573Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07439887","Phase 1\u002F2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease",[12],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:27.402661Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07161544","A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)",[12],"2026-08-26T02:15:01.639696Z","2026-05-05T02:35:31.913516Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT07419334","Study of ALK-001 on the Progression of Stargardt Disease",[38],"Phase 3","2026-08-26T02:16:38.897933Z","2026-04-29T02:57:57.076637Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT06319872","The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration",[45],"Phase 1","2026-08-26T02:16:38.053590Z","2026-05-05T02:43:27.673519Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07594236","Phase 1 Study of C.001 in Retinal Degeneration",[45],"2026-08-26T02:18:51.009190Z","2026-05-29T15:36:40.205951Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT03011541","Stem Cell Ophthalmology Treatment Study II",[],"2026-08-26T02:17:33.002248Z","2026-05-05T02:43:29.077392Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07425574","A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults",[],"2026-08-26T02:16:01.910993Z","2026-07-19T19:36:05.078333Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06445322","Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)",[],"2026-08-26T02:18:15.214990Z","2026-05-13T02:55:06.493722Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":52,"content_modified":76},"NCT06435000","An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene",[],"2026-05-13T02:55:06.493058Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT06805474","A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT",[],"2026-08-26T02:17:48.768272Z","2026-05-13T02:55:06.580468Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT02617966","Rod and Cone Mediated Function in Retinal Disease",[],"2026-08-26T02:18:54.586325Z","2026-05-13T02:55:06.098265Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT02435940","Inherited Retinal Degenerative Disease Registry",[],"2026-08-26T02:16:07.529922Z","2026-05-13T02:55:06.097266Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT01866371","High Resolution Retinal Imaging",[],"2026-08-26T02:17:30.961790Z","2026-05-13T02:55:06.078191Z",{"nct_id":102,"title":103,"phases":104,"status":105,"updated_at":106,"content_modified":107},"NCT04545736","Oral Metformin for Treatment of ABCA4 Retinopathy",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:54:23.387833Z","2026-05-05T02:43:29.475371Z",{"nct_id":109,"title":110,"phases":111,"status":105,"updated_at":112,"content_modified":113},"NCT06591806","An Observational Study in Children and Adults With Stargardt Disease",[],"2026-08-03T02:06:20.225302Z","2026-05-13T02:55:06.552080Z",[115],{"biomarker":116,"count":117,"slug":118},"Retinal-Specific Phospholipid-Transporting ATPase ABCA4",9,"retinal-specific-phospholipid-transporting-atpase-abca4",[120,124,128,132,136,140,144,147,150,154],{"state":121,"count":122,"slug":123},"Texas",10,"texas",{"state":125,"count":126,"slug":127},"Florida",8,"florida",{"state":129,"count":130,"slug":131},"California",7,"california",{"state":133,"count":134,"slug":135},"Maryland",6,"maryland",{"state":137,"count":138,"slug":139},"Michigan",5,"michigan",{"state":141,"count":142,"slug":143},"Massachusetts",4,"massachusetts",{"state":145,"count":142,"slug":146},"Oregon","oregon",{"state":148,"count":142,"slug":149},"Pennsylvania","pennsylvania",{"state":151,"count":152,"slug":153},"Arizona",3,"arizona",{"state":155,"count":152,"slug":156},"Ohio","ohio"]